This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

EU regulators gear up for pharma reform as generics warn of new burdens

By Inbar Preiss ( February 26, 2026, 17:17 GMT | Insight) -- The EU is finalizing a major overhaul of its pharmaceutical rules. While generic drugmakers welcome steps that could speed up market entry, they warn that new supply requirements and procedural changes may create legal uncertainty and add costs during implementation.The pharmaceutical industry is preparing for the rollout of the EU’s pharmaceutical legislation reform; an overhaul of rules that have governed the sector for more than 20 years....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections